Sarepta Therapeutics(SRPT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SRPT Sarepta Therapeutics

交易中 10-13 13:59:24 EDT

16.69

-0.75

-4.30%

最高17.23	最低16.41	成交量146.98万
今开17.12	昨收17.44	日振幅4.69%
总市值17.62亿	流通市值16.53亿	总股本1.06亿
成交额2,457万	换手率1.48%	流通股本9,905万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SRPT","market":"US","secType":"STK","nameCN":"Sarepta Therapeutics","latestPrice":16.69,"timestamp":1791914363915,"preClose":17.44,"halted":0,"volume":1469796,"delay":0,"changeRate":-0.0430045871559633,"floatShares":99052564,"shares":105571146,"eps":-1.316144,"marketStatus":"交易中","change":-0.75,"latestTime":"10-13 13:59:24 EDT","open":17.12,"high":17.228,"low":16.41,"amount":24570022.679316,"amplitude":0.046904,"askPrice":16.7,"askSize":200,"bidPrice":16.68,"bidSize":249,"shortable":3,"etf":0,"ttmEps":-1.316144,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1791921600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":865396800000,"exchange":"NASDAQ","adjPreClose":17.44,"preHourTrading":{"tag":"盘前","latestPrice":17.18,"preClose":17.44,"latestTime":"09:28 EDT","volume":6486,"amount":112366.389186,"timestamp":1791898137051,"change":-0.26,"changeRate":-0.014908,"amplitude":0.053326},"postHourTrading":{"tag":"盘后","latestPrice":17.45,"preClose":17.44,"latestTime":"19:36 EDT","volume":714780,"amount":12465873.1605,"timestamp":1791848211962,"change":0.01,"changeRate":0.000573,"amplitude":0.014335},"volumeRatio":0.690298,"impliedVol":0.9548,"impliedVolPercentile":0.7291},"requestUrl":"/m/hq/s/SRPT","defaultTab":"news","newsList":[{"id":"1121162041","title":"Sarepta Therapeutics公布2026-2027学年Route 79杜氏奖学金项目获奖名单","url":"https://stock-news.laohu8.com/highlight/detail?id=1121162041","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121162041?lang=zh_cn&edition=full","pubTime":"2026-09-08 21:01","pubTimestamp":1788872496,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics宣布了2026-2027学年Route 79杜氏奖学金项目的获奖者名单。该奖学金计划旨在支持患有杜氏肌营养不良症的学生，助力他们在学术道路上继续前行，追逐梦想。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","SRPU","IE0002141913.USD","BK4139","IE00B2B36J28.USD","IE00BJT1NW94.SGD","SRPT","IE00BFTCPJ56.SGD","BK4585","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133135751","title":"木头姐周四大举加仓特斯拉与Snowflake，连续抛售Roku近1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133135751","media":"老虎资讯综合","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133135751?lang=zh_cn&edition=full","pubTime":"2026-06-19 16:31","pubTimestamp":1781857919,"startTime":"0","endTime":"0","summary":"Snowflake此前公布的2027财年第一季度业绩表现强劲，营收同比增长33%至13.9亿美元，经调整后每股收益39美分，均优于市场预期。继续减持Roku，套现近1亿美元与此同时，Ark继续大幅减仓Roku。事实上，本周以来Ark已连续抛售Roku股票。从本轮调仓来看，Ark继续加码AI基础设施和高成长科技股，重点押注特斯拉与Snowflake等长期增长标的，同时持续降低Roku相关仓位，显示其对AI与自动化主题的配置倾向进一步增强。","market":"us","thumbnail":"https://static.tigerbbs.com/0fb0479ff67cd3a760cdce353bcb60ed","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0fb0479ff67cd3a760cdce353bcb60ed"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"木头姐周四大举加仓特斯拉与Snowflake，连续抛售Roku近1亿美元","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKX","ARKK","CRSH","TSLI","07766","TSLA","TSLR","TSL","TESL","09366","TWST","ROKU","SNOW","TSLW","TSLO","TSYY","ELIS","LLYX","SNOY","LLY","SRPT","ARKG","TSLG","07366","09766","TSII","TSLQ","ARKQ","ARKW","SNOU","LLII","ELIL","TSDD","TSLP","TSLT","SRPU","TEST","LLYZ","TSLZ","TSLL","TLA","TSLS","TSLY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1118932123","title":"财报前瞻｜Sarepta Therapeutics本季度营收预计同比下降30.61%，机构观点偏看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1118932123","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118932123?lang=zh_cn&edition=full","pubTime":"2026-04-29 15:46","pubTimestamp":1777448804,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics将于2026年05月06日发布财报，市场关注本季营收与盈利拐点的同步出现及基因疗法商业化节奏。市场一致预期本季度公司营收为4.74亿美元，同比下降30.61%；调整后每股收益为0.99美元，同比上升204.75%，显示在收入同比承压的前提下，盈利端有望出现显著改善；公司上季度未披露本季度的收入或利润指引。公司当前主营由产品销售贡献3.70亿美元，占比83.45%，在整体营收同比下降32.73%的环境下，核心商业化产品仍是基本盘。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜Sarepta Therapeutics本季度营收预计同比下降30.61%，机构观点偏看多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRPT"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2518462278","title":"Sarepta Therapeutics, Inc.跌2.94% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2518462278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518462278?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:09","pubTimestamp":1741615795,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时09分，Sarepta Therapeutics, Inc.股票出现波动，股价大幅跳水2.94%。Sarepta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3218.06%、697.98%、112.83%，振幅较大的相关个股有Scisparc Ltd.、Pmgc Holdings Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、32.14%、30.70%。Sarepta Therapeutics, Inc.公司简介：Sarepta Therapeutics公司是一家专注于治疗罕见、传染病和其他疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022095596403f8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022095596403f8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IE00BFTCPJ56.SGD","SRPT","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4585","IE0002141913.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517469013","title":"Sarepta Therapeutics(SRPT.US)获Scotiabank首次覆盖，给予与大盘持平评级, 目标价105.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517469013","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517469013?lang=zh_cn&edition=full","pubTime":"2025-03-08 06:13","pubTimestamp":1741385581,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics(SRPT.US)获Scotiabank首次覆盖，给予与大盘持平评级, 目标价105.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08061348605304.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","SRPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516938650","title":"Sarepta Therapeutics, Inc.盘中异动 下午盘股价大跌5.00%报101.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516938650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516938650?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:27","pubTimestamp":1741030063,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时27分，Sarepta Therapeutics, Inc.股票出现波动，股价大幅下跌5.00%。Sarepta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4540.23%、206.18%、181.06%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Sarepta Therapeutics, Inc.公司简介：Sarepta Therapeutics公司是一家专注于治疗罕见、传染病和其他疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304032743abe68594&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304032743abe68594&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IE0009355771.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4139","IE00BJT1NW94.SGD","SRPT","BK4585","IE00B2B36J28.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516554802","title":"Sarepta Therapeutics, Inc.2024财年实现净利润2.35亿美元，同比增加143.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516554802","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516554802?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:01","pubTimestamp":1740931283,"startTime":"0","endTime":"0","summary":"3月3日，Sarepta Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为2.35亿美元，同比增加143.84%；其中营业收入为19.02亿美元，同比增加53.02%，每股基本收益为2.47美元。从资产负债表来看，Sarepta Therapeutics, Inc.总负债24.35亿美元，其中短期债务13.27百万美元，资产负债比为1.63，流动比率为4.20。机构评级：截至2025年3月3日，当前有20家机构对Sarepta Therapeutics, Inc.目标价做出预测，其中目标均价为179.80美元，其中最低目标价为75.00美元，最高目标价为215.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000209abe4acf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000209abe4acf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SRPT","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514376554","title":"Sarepta Therapeutics, Inc.盘中异动 急速拉升5.13%报108.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514376554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514376554?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:27","pubTimestamp":1740756443,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时27分，Sarepta Therapeutics, Inc.股票出现波动，股价快速上涨5.13%。Sarepta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Bioxcel Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Puma Biotechnology Inc涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1443.74%、406.33%、338.55%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Bioxcel Therapeutics, Inc.，振幅分别为46.60%、43.37%、38.73%。Sarepta Therapeutics, Inc.公司简介：Sarepta Therapeutics公司是一家专注于治疗罕见、传染病和其他疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228232723989686a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228232723989686a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IE00B2B36J28.USD","IE0009355771.USD","SRPT","BK4585","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","BK4139","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128208358","title":"萨瑞普塔治疗公司2024年第四季度调整后每股收益$1.90，符合预期，销售额$6.58412亿高于预期$6.27582亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1128208358","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128208358?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:10","pubTimestamp":1740604244,"startTime":"0","endTime":"0","summary":"萨瑞普塔治疗公司报告季度收益为每股$1.90，与分析师的共识预期一致。相比去年同期每股收益$0.82，增长了131.71%。公司报告的季度销售额为$6.58412亿，高出分析师预期的$6.27582亿，增幅达4.91%。与去年同期销售额$3.96781亿相比，这一销售额增加了65.94%。以上内容来自Benzinga Earnings专栏，原文如下：$Sarepta Therapeutics$  reported quarterly earnings of $1.90 per share which met the analyst consensus estimate. This is a 131.71 percent increase over earnings of $0.82 per share from the same period last year.  The company reported quarterly sales of $658.412 million which beat the analyst consensus estimate of $627.582 ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"萨瑞普塔治疗公司2024年第四季度调整后每股收益$1.90，符合预期，销售额$6.58412亿高于预期$6.27582亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512516523","title":"Sarepta Therapeutics, Inc.盘中异动 股价大跌5.52%报101.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512516523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512516523?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889108,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Sarepta Therapeutics, Inc.股票出现异动，股价大幅下跌5.52%。截至发稿，该股报101.99美元/股，成交量7.9198万股，换手率0.08%，振幅1.69%。Sarepta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Sarepta Therapeutics, Inc.公司简介：Sarepta Therapeutics公司是一家专注于治疗罕见、传染病和其他疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822314996279715&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822314996279715&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4585","IE0009355771.USD","IE0002141913.USD","IE00B2B36J28.USD","SRPT","IE00BJJMRZ35.SGD","BK4139","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509407788","title":"Sarepta Therapeutics, Inc.盘中异动 下午盘快速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509407788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509407788?lang=zh_cn&edition=full","pubTime":"2025-02-07 03:26","pubTimestamp":1738870000,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日03时26分，Sarepta Therapeutics, Inc.股票出现波动，股价快速下跌5.02%。Sarepta Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Lipella Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为6915.03%、1742.52%、176.11%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为125.58%、69.09%、64.30%。Sarepta Therapeutics, Inc.公司简介：Sarepta Therapeutics公司是一家专注于治疗罕见、传染病和其他疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207032641987cb825&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207032641987cb825&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","SRPT","IE00BJT1NW94.SGD","IE0009355771.USD","LENZ","IE0002141913.USD","BK4585","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509321352","title":"Sarepta Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509321352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509321352?lang=zh_cn&edition=full","pubTime":"2025-02-06 02:04","pubTimestamp":1738778657,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日02时04分，Sarepta Therapeutics, Inc.股票出现波动，股价快速拉升5.00%。Sarepta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.07%。其相关个股中，Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4544.68%、2237.70%、1686.74%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为122.81%、99.51%、59.58%。Sarepta Therapeutics, Inc.公司简介：Sarepta Therapeutics公司是一家专注于治疗罕见、传染病和其他疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206020417987b9e0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206020417987b9e0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0002141913.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4585","SRPT","BK4139","IE00BJJMRZ35.SGD","LENZ","IE00BJT1NW94.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507644241","title":"HC Wainwright & Co.：重申Sarepta Therapeutics(SRPT.US)评级，由卖出调整至卖出评级, 目标价由75.00美元调整至75.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507644241","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507644241?lang=zh_cn&edition=full","pubTime":"2025-01-30 19:54","pubTimestamp":1738238063,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Sarepta Therapeutics(SRPT.US)评级，由卖出调整至卖出评级, 目标价由75.00美元调整至75.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/30195447908892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SRPT","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504449484","title":"特朗普2.0时代即将开启，投资机会如何掘金？","url":"https://stock-news.laohu8.com/highlight/detail?id=2504449484","media":"招商基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504449484?lang=zh_cn&edition=full","pubTime":"2025-01-20 10:36","pubTimestamp":1737340585,"startTime":"0","endTime":"0","summary":"美国候任总统唐纳德·特朗普将于美东时间1月20日12时正式宣誓就任美国第47任总统。特朗普2.0时代即将开启，有哪些投资机会可以布局？值得一提的是，科技股在特朗普任期内表现尤为突出，成为推动美股上涨的主要力量。在特朗普第一个任期内，美元整体表现相对弱势。4年任期内，美元指数累计下跌了10.53%。而纵观全球市场，在特朗普上一任期内，恒生科技指数涨幅超过147%，表现甚至略微优于纳斯达克指数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NWSA","PFG","PODD","BK4585","PSQ","FYBR","INCY","GMAB","ZS","FOXA","LOGI","AAON","FWONK","ORLY","ULTA","TROW","LI","WYNN","ERIE","BK4588","QCOM","JKHY","PNFP","MPWR","SFM","EWBC","ROST","ILMN","CBSH","META","MNST","CRWD","BK4550","NICE","BK4593","SMCI","TER","TCOM","GLPI","RADX","CDNS","BMRN","CWST","FTNT","SNPS","PCAR","PEP","AAL","STX","LAMR","AKAM","EA","CTAS","FCNCA","GNTX","MRVL","NVIW.SI","EXAS","FOX","PAYX","TSCO","TTEK","NTAP","COIN","FFIV","FER","NFLX","NTRA","ESLT","MMYT","CPB","INTU","PARA","BPMC","CFLT","LSTR","POOL","LU1815336091.USD","PCVX","RKLB","ADBE","CME","ARGX","QQQ","DPZ","NTNX","WBA","GILD","AVGO","OLED","AMD","NXPI","AMAT","CHRW","LKQ","PLTR","GEN","WWD","HTHT","DUOL","LU0757428866.USD","GOOGL","TEAM","NVMI","MTCH","ARM","BK4086","JD","NDAQ","CASY","NBIX","SWKS","WTFC","ERIC","TTWO","SEIC","CSGP","MSFT","REGN","ZM","AAPL","EQIX","PDD","MELI","SAIA","CHTR","TTD","BPOP","CSWI","HOOD","OTEX","DOX","CHKP","HOLX","SRPT","DSGX","TRMB","MCHP","ASML","TMUS","KDP","LECO","ANSS","HON","TLN","MTSI","ON","HSIC","ALAB","ALNY","AXON","LU2065731478.USD","RGEN","SOFI","PCTY","TECH","SQQQ","COO","CZR","ROKU","RGLD","PAA","SIRI","BK4561","CG","QID","SBUX","RPRX","JBHT","HST","BRKR","RVMD","BKR","AMZN","ICLR","AEP","TXN","MARA","NDSN","ROIV","CHDN","CPRT","DLTR","OKTA","APA","ISRG","MANH","LULU","INSM","AUR","CINF","GRAB","ITCI","TSLA","TSYW.SI","AMGN","MRNA","DOCU","Z","CHRD","FSV","INTC","WDC","LIN","NTRS","LNW","CCEP","CEG","MIDD","ROP","FAST","MNQmain","BKNG","HQY","LNT","ADSK","QXO","RIVN","MKTX","MNDY","ENPH","GEHC","BK4534","ODFL","EBAY","PTC","HBAN","FSLR","AZN","MDB","MDLZ","AFRM","ENTG","CSCO","SBAC","RYAAY","IDXX","MKSI","BK4581","CYBR","LSCC","EXPE","STLD","CTSH","BIIB","ONC","TQQQ","DKNG","GTLB","EXE","LU0053671581.USD","TPG","HLNE","DASH","QLD","NVDA","NTES","TW","KHC","USJW.SI","BSY","FRPT","NQmain","COST","EVRG",".IXIC","CDW","COKE","TSEM","MEDP","ADI","FTAI","AGNC","SSNC","REG","CSX","QRVO","USAW.SI","DDOG","ALGN","LPLA"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2488167732","title":"Sarepta Therapeutics, Inc.盘中异动 早盘大幅下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488167732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488167732?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:51","pubTimestamp":1733151074,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时51分，Sarepta Therapeutics, Inc.股票出现异动，股价快速下挫5.02%。Sarepta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Senti Biosciences, Inc.、Cingulate Inc C/Wts 10/12/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Senti Biosciences, Inc.、Purple Biotech Ltd、Revelation Biosciences, Inc.较为活跃，换手率分别为1060.28%、781.47%、211.79%，振幅较大的相关个股有Senti Biosciences, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为136.57%、64.17%、43.48%。Sarepta Therapeutics, Inc.公司简介：Sarepta Therapeutics公司是一家专注于治疗罕见、传染病和其他疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202225114abf00b7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202225114abf00b7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJT1NW94.SGD","BK4139","LENZ","IE0002141913.USD","IE0009355771.USD","IE00B2B36J28.USD","SRPT","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486001158","title":"Sarepta Therapeutics, Inc.盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486001158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486001158?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:34","pubTimestamp":1732631660,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时34分，Sarepta Therapeutics, Inc.股票出现波动，股价大幅拉升5.08%。Sarepta Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Poseida Therapeutics, Inc.、Fate Therapeutics, Inc.、Arrowhead Pharmaceuticals, Inc.涨幅较大，Oncternal Therapeutics, Inc.、Poseida Therapeutics, Inc.、Cognition Therapeutics, Inc.较为活跃，换手率分别为13.86%、10.42%、8.61%，振幅较大的相关个股有Exicure, Inc.、Caribou Biosciences, Inc.、Cabaletta Bio, Inc.，振幅分别为14.25%、13.61%、13.54%。Sarepta Therapeutics, Inc.公司简介：Sarepta Therapeutics公司是一家专注于治疗罕见、传染病和其他疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223421971a8a0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223421971a8a0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SRPT","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LENZ","IE0009355771.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126564074","title":"华尔街准备迎接特朗普时代的并购潮：哪些公司将成为新宠？","url":"https://stock-news.laohu8.com/highlight/detail?id=1126564074","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126564074?lang=zh_cn&edition=full","pubTime":"2024-11-18 11:31","pubTimestamp":1731900702,"startTime":"0","endTime":"0","summary":"随着特朗普即将就任美国总统，华尔街对并购活动可能复苏充满期待。然而，随着美国大选结束，FTC 的领导层可能发生改变，华尔街正为一个新的并购时代做好准备。潜在趋势特朗普的胜选恰逢并购业务已开始复苏的节点。被法官阻止后上周两家公司宣布终止合并，但未来仍可能参与其他交易。潜在问题虽然特朗普的第二个任期预计将比拜登总统更有利于商业，但新政府的反垄断政策仍存在不确定性。","market":"us","thumbnail":"https://static.tigerbbs.com/1132cf4a91e17479cbdbd4a7fdf04a3b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1132cf4a91e17479cbdbd4a7fdf04a3b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"华尔街准备迎接特朗普时代的并购潮：哪些公司将成为新宠？","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAVE","COF","BROS","DUOL","FRPT","HIMS","SRPT","DFS","FOUR","S","EA","ELF","TPR","ZM"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2483309832","title":"Sarepta Therapeutics, Inc.2024财年第三财季实现净利润33.61百万美元，同比增加182.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483309832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483309832?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686428,"startTime":"0","endTime":"0","summary":"11月16日，Sarepta Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为33.61百万美元，同比增加182.10%；其中营业收入为4.67亿美元，同比增加40.66%，每股基本收益为0.35美元。从资产负债表来看，Sarepta Therapeutics, Inc.总负债23.79亿美元，其中短期债务91.60百万美元，资产负债比为1.52，流动比率为3.85。机构评级：截至2024年11月16日，当前有20家机构对Sarepta Therapeutics, Inc.目标价做出预测，其中目标均价为192.00美元，其中最低目标价为150.00美元，最高目标价为219.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000208a23b88d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000208a23b88d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SRPT","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143231034","title":"异动解读 | Sarepta Therapeutics业绩超预期 主力产品销售增长推动股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1143231034","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143231034?lang=zh_cn&edition=full","pubTime":"2024-11-08 00:58","pubTimestamp":1730998728,"startTime":"0","endTime":"0","summary":"美国生物制药公司Sarepta Therapeutics11月7日盘前大涨近4%,股价上涨至132.97美元。公司此前公布的第三季度财报数据显示,营收4.672亿美元,高于华尔街分析师此前的4.093亿美元预期,主要得益于旗舰产品Elevidys销售表现亮眼。Elevidys是SRPT公司主要针对治疗罕见疾病杜氏肌营养不良症推出的基因疗法药物,第三季度产品净收入达1.81亿美元。公司称,该药品能有效改善该疾病 young患者的生存质量。杜氏肌营养不良症会导致骨骼及心肌变弱无力,患者病情随时间推移会迅速恶化。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Sarepta Therapeutics业绩超预期 主力产品销售增长推动股价大涨","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SRPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2474274746","title":"Sarepta Therapeutics, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474274746","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2474274746?lang=zh_cn&edition=full","pubTime":"2024-10-10 22:48","pubTimestamp":1728571683,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日22时48分，Sarepta Therapeutics, Inc.股票出现波动，股价急速上涨5.00%。Sarepta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Aditxt, Inc.、Tempest Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为278.51%、149.24%、107.68%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为66.67%、49.35%、40.50%。Sarepta Therapeutics, Inc.公司简介：Sarepta Therapeutics公司是一家专注于治疗罕见、传染病和其他疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101022480398e3bbf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101022480398e3bbf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","SRPT","IE00BJT1NW94.SGD","BK4139","IE0009355771.USD","BK4585","IE0002141913.USD","LENZ","IE00BJJMRZ35.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sarepta.com","stockEarnings":[{"period":"1week","weight":-0.0029},{"period":"1month","weight":-0.1472},{"period":"3month","weight":-0.029},{"period":"6month","weight":-0.1974},{"period":"1year","weight":-0.2112},{"period":"ytd","weight":-0.1896}],"compareEarnings":[{"period":"1week","weight":0.0042},{"period":"1month","weight":0.0181},{"period":"3month","weight":0.0349},{"period":"6month","weight":0.1117},{"period":"1year","weight":0.1915},{"period":"ytd","weight":0.141}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sarepta Therapeutics, Inc.于1980年7月22日在俄勒冈州注册成立。该公司是一家商业化阶段的生物制药公司，专注于发现和开发独特的RNA靶向疗法、基因疗法和其他遗传治疗方式，用于治疗罕见病。它已开发出多种获批的杜氏肌营养不良症治疗药物，并正在推进针对其他神经肌肉和骨骼疾病的候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.052169},{"month":2,"riseRate":0.571429,"avgChangeRate":0.030294},{"month":3,"riseRate":0.5,"avgChangeRate":0.013831},{"month":4,"riseRate":0.285714,"avgChangeRate":0.007228},{"month":5,"riseRate":0.642857,"avgChangeRate":0.112993},{"month":6,"riseRate":0.714286,"avgChangeRate":0.046133},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.016443},{"month":8,"riseRate":0.733333,"avgChangeRate":0.107102},{"month":9,"riseRate":0.533333,"avgChangeRate":0.111486},{"month":10,"riseRate":0.4,"avgChangeRate":-0.067177},{"month":11,"riseRate":0.714286,"avgChangeRate":0.074513},{"month":12,"riseRate":0.571429,"avgChangeRate":0.010915}],"exchange":"NASDAQ","name":"Sarepta Therapeutics","nameEN":"Sarepta Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sarepta Therapeutics(SRPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sarepta Therapeutics(SRPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sarepta Therapeutics,SRPT,Sarepta Therapeutics股票,Sarepta Therapeutics股票老虎,Sarepta Therapeutics股票老虎国际,Sarepta Therapeutics行情,Sarepta Therapeutics股票行情,Sarepta Therapeutics股价,Sarepta Therapeutics股市,Sarepta Therapeutics股票价格,Sarepta Therapeutics股票交易,Sarepta Therapeutics股票购买,Sarepta Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sarepta Therapeutics(SRPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sarepta Therapeutics(SRPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}